Paper Details

  1. Home
  2. Paper Details

5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.

Author: SaifMuhammad Wasif, von BorstelReid

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study found that PN401, an oral prodrug of uridine, can increase the efficacy of 5-fluorouracil (5-FU) in mice bearing Colon 26 adenocarcinoma. PN401 can also be used as an antidote to 5-FU overdose.
Paper Details　
Original Abstract of the Article :
PURPOSE: PN401, an oral prodrug of uridine yields more bioavailable uridine than oral administration of uridine itself. PN401 may therefore be useful for permitting dose escalation of 5-fluorouracil (5-FU) with consequent improvements in antitumor efficacy. EXPERIMENTAL DESIGN: Female BALB/c mice (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00280-005-0129-x

データ提供：米国国立医学図書館（NLM）

Boosting 5-Fluorouracil: A New Approach to Cancer Treatment

Cancer treatment is a challenging journey, and finding ways to enhance the effectiveness of chemotherapy drugs is a constant quest. This study investigates the potential of PN401, an oral prodrug of uridine, to enhance the efficacy of 5-fluorouracil (5-FU) in mice with colon cancer. The study found that combining PN401 with 5-FU increased the tolerated dose of 5-FU and improved antitumor activity, potentially paving the way for more effective cancer treatment. This research is like uncovering a hidden spring in the desert of cancer treatment, offering a new source of hope for patients.

PN401 and 5-Fluorouracil: A Synergistic Approach

The study demonstrates that PN401 can significantly enhance the efficacy of 5-FU in mice with colon cancer. The combination resulted in increased tumor response and prolonged survival compared to 5-FU alone. This exciting discovery could lead to improved cancer treatment outcomes for patients. This is like a new caravan route in the desert of cancer treatment, offering a more efficient and successful path for patients.

The Future of Cancer Treatment: A New Oasis of Hope

This study suggests that PN401 could be a valuable tool for enhancing the effectiveness of 5-FU in cancer treatment. Further research is needed to explore the potential of this combination in human patients. It's like a beacon of hope in the desert of cancer treatment, offering a promising new approach to combatting this challenging disease.

Dr.Camel's Conclusion

This research presents a promising new strategy for improving cancer treatment. The researchers have skillfully navigated the complexities of chemotherapy drug combinations, offering a beacon of hope for patients. Just as a skilled desert explorer discovers a hidden oasis, this research has uncovered a potential breakthrough in cancer treatment, offering a new path to healing.

Date :
  1. Date Completed 2006-07-05
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

16187114

DOI: Digital Object Identifier

10.1007/s00280-005-0129-x

Related Literature

Article Analysis
・Effects of uridine triacetate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.